Osteogenic Differentiation via Small Molecule Signaling

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for inducing pluripotent stem cells to differentiate into osteocytes are inefficient, unreliable, and costly, lacking a simple, short-term, and highly reproducible approach suitable for bone regeneration therapies and drug development for bone diseases.

Innovation Solution

A method involving culturing pluripotent stem cells under feeder-free conditions in a mixed medium with a ROCK inhibitor and retinoic acid receptor agonist, followed by osteogenic induction, achieving osteogenic differentiation within 12 days or less.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If embryoid body formation method is used, then the process is relatively simple, but the results are not constant and embryoid bodies must be formed

Engineering Contradiction:

Improveprocess simplicityVSAvoiddifferentiation consistency

Core Design Contradiction:

Ease of manufactureVSReliability

Solution Approach 1:

The invention changes the chemical parameters of the culture medium by specifying precise concentrations of small molecule compounds (e.g., CHIR99021 at 3 μM, IWP-2 at 1 μM, SB431542 at 10 μM, LDN-193189 at 3 μM) to achieve reliable osteogenic differentiation without embryoid body formation, resolving the contradiction between simplicity and consistency

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The invention replaces expensive biologics with small molecule compounds that are cheaper and more stable, enabling consistent results without the need for forming and maintaining embryoid bodies, thus improving both simplicity and reliability

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

2Manufacturing precision

If multi-step induction method is used, then the developmental process is faithfully recapitulated, but the induction efficiency varies and multiple expensive biologics are required

Engineering Contradiction:

Improvedevelopmental process accuracyVSAvoidnumber of compounds and steps

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention segments the osteogenic differentiation process into distinct time-based stages (Days 0-3, Days 4-6, Days 7-12) with specific small molecule compounds for each stage, achieving faithful developmental recapitulation through a simplified three-stage protocol rather than multiple complex steps

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The invention replaces multiple expensive biologics with stable small molecule compounds that can be stored and used consistently, reducing both the number of compounds needed and the overall cost while maintaining high induction efficiency

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

3Productivity

If conventional methods are used, then osteoblasts can be induced, but terminally differentiated osteocytes cannot be effectively induced

Engineering Contradiction:

Improveosteoblast induction efficiencyVSAvoidosteocyte differentiation efficiency

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The invention maintains continuous osteogenic induction through sequential addition of small molecule compounds over 12 days, with the final stage (Days 7-12) using osteogenic medium plus LDN-193189 and retinoic acid to continuously drive differentiation to terminally differentiated osteocytes, achieving both high productivity and reliability

Inventive Principle:

Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a simple, efficient, and highly reproducible process for inducing osteogenic differentiation, suitable for bone regeneration and drug screening, with reduced costs and improved induction efficiency compared to existing methods.

Implementation Method 1

culturing the cells in a mixed culture medium of an osteogenic induction medium and a pluripotent stem cell medium, the mixed culture medium containing a ROCK inhibitor and a retinoic acid receptor α or β agonist

Methodology Applied

Scientific EffectROCK inhibitor signaling:

Implementation Method 2

the mixed culture medium containing a ROCK inhibitor and a retinoic acid receptor α or β agonist

Methodology Applied

Scientific EffectRetinoic acid receptor agonist signaling:

Data Source

PatentUS11859209B2Method for inducing osteogenic differentiation

Publication Date: 2024.01.02 KYOTO UNIV

AI summary

The present invention provides a method for inducing osteogenic differentiation, the method comprising the following steps of: (1) culturing pluripotent stem cells under feeder-free conditions, (2) culturing the cells in a mixed culture medium of an osteogenic induction medium and a pluripotent stem cell medium, the mixed culture medium containing a ROCK inhibitor and a retinoic acid receptor α or β agonist, and (3) culturing the cells in an osteogenic induction medium containing the retinoic acid receptor α or β agonist. The method for inducing osteogenic differentiation according to the present invention is a simple, short-term, highly efficient and highly reproducible one-procedure method for inducing osteogenic differentiation, wherein the method is suitable for bone regeneration therapies, the development of bone metabolic drugs and the development of novel therapies for bone diseases.